Evaluation of efficacy and safety of lanthanum carbonate in hyperphosphatemia patients on dialysis with either 2.5 or 3.0 mEq/L of dialysate calcium concentratio
Phase 4
- Conditions
- Maintenance hemodialysis patients with hyperphosphatemia
- Registration Number
- JPRN-UMIN000002820
- Lead Sponsor
- Rakuwakai Otowa Kinen Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Pts who meet the contraindiation criteria in package insert of lanthanum carbonate 2) Pregnant or possibly pregnant pts, pts on lactation 3) Inappropriate pts for this study according to the investigator's judgment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum phosphate, serum calcium and serum Ca x P product level and intact-PTH
- Secondary Outcome Measures
Name Time Method Adverse events, drug compliance